Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 24 entries
Sorted by: Best Match Show Resources per page
Reply to reinhold et al .

Immunology today

Rubartelli A, Poggi A, Sitia R, Zocchi MR.
PMID: 10431253
Immunol Today. 1999 Aug;20(8):384-5. doi: 10.1016/s0167-5699(99)01490-5.

No abstract available.

Cite
Rubartelli A, Poggi A, Sitia R, et al. Reply to reinhold et al . Immunol Today. 1999;20(8):384-5doi: 10.1016/s0167-5699(99)01490-5.
Rubartelli, A., Poggi, A., Sitia, R., & Zocchi, M. R. (1999). Reply to reinhold et al . Immunology today, 20(8), 384-5. https://doi.org/10.1016/s0167-5699(99)01490-5
Rubartelli, et al. "Reply to reinhold et al ." Immunology today vol. 20,8 (1999): 384-5. doi: https://doi.org/10.1016/s0167-5699(99)01490-5
Rubartelli A, Poggi A, Sitia R, Zocchi MR. Reply to reinhold et al . Immunol Today. 1999 Aug;20(8):384-5. doi: 10.1016/s0167-5699(99)01490-5. PMID: 10431253.
Copy Download .nbib Format: NLM
Contrast-enhanced ultrasound findings in soft-tissue lesions: preliminary results.

Journal of ultrasound

Stramare R, Gazzola M, Coran A, Sommavilla M, Beltrame V, Gerardi M, Scattolin G, Faccinetto A, Rastrelli M, Grisan E, Montesco MC, Rossi CR, Rubaltelli L.
PMID: 24046796
J Ultrasound. 2013 Feb 23;16(1):21-7. doi: 10.1007/s40477-013-0005-1. eCollection 2013.

OBJECTIVES: There is currently no widely available, minimally invasive first-level examination that allows physicians to identify soft-tissue lesions that are likely to be malignant. The aim of this pilot study was to explore the potential suitability of dynamic contrast-enhanced...

Cite
Stramare R, Gazzola M, Coran A, et al. Contrast-enhanced ultrasound findings in soft-tissue lesions: preliminary results. J Ultrasound. 2013;16(1):21-7doi: 10.1007/s40477-013-0005-1.
Stramare, R., Gazzola, M., Coran, A., Sommavilla, M., Beltrame, V., Gerardi, M., Scattolin, G., Faccinetto, A., Rastrelli, M., Grisan, E., Montesco, M. C., Rossi, C. R., & Rubaltelli, L. (2013). Contrast-enhanced ultrasound findings in soft-tissue lesions: preliminary results. Journal of ultrasound, 16(1), 21-7. https://doi.org/10.1007/s40477-013-0005-1
Stramare, R, et al. "Contrast-enhanced ultrasound findings in soft-tissue lesions: preliminary results." Journal of ultrasound vol. 16,1 (2013): 21-7. doi: https://doi.org/10.1007/s40477-013-0005-1
Stramare R, Gazzola M, Coran A, Sommavilla M, Beltrame V, Gerardi M, Scattolin G, Faccinetto A, Rastrelli M, Grisan E, Montesco MC, Rossi CR, Rubaltelli L. Contrast-enhanced ultrasound findings in soft-tissue lesions: preliminary results. J Ultrasound. 2013 Feb 23;16(1):21-7. doi: 10.1007/s40477-013-0005-1. eCollection 2013. PMID: 24046796; PMCID: PMC3774904.
Copy Download .nbib Format: NLM
Production and secretion of interleukin 1 receptor antagonist in monocytes and keratinocytes.

Cytotechnology

Corradi A, Bajetto A, Cozzolino F, Rubartelli A.
PMID: 22358708
Cytotechnology. 1993 Jan;11:S50-2. doi: 10.1007/BF00746053.

IL-1 receptor antagonist (IL-1ra) is a newly described member of the IL-1 family, isolated from supernatants of Ig stimulated monocytes, that binds competitively to IL-1 receptors without stimulating target cells (1-3). Also epithelial cells produce IL-1ra in a form...

Cite
Corradi A, Bajetto A, Cozzolino F, et al. Production and secretion of interleukin 1 receptor antagonist in monocytes and keratinocytes. Cytotechnology. 1993;11:S50-2doi: 10.1007/BF00746053.
Corradi, A., Bajetto, A., Cozzolino, F., & Rubartelli, A. (1993). Production and secretion of interleukin 1 receptor antagonist in monocytes and keratinocytes. Cytotechnology, 11S50-2. https://doi.org/10.1007/BF00746053
Corradi, A, et al. "Production and secretion of interleukin 1 receptor antagonist in monocytes and keratinocytes." Cytotechnology vol. 11 (1993): S50-2. doi: https://doi.org/10.1007/BF00746053
Corradi A, Bajetto A, Cozzolino F, Rubartelli A. Production and secretion of interleukin 1 receptor antagonist in monocytes and keratinocytes. Cytotechnology. 1993 Jan;11:S50-2. doi: 10.1007/BF00746053. PMID: 22358708.
Copy Download .nbib Format: NLM
Consensus guidelines for the detection of immunogenic cell death.

Oncoimmunology

Kepp O, Senovilla L, Vitale I, Vacchelli E, Adjemian S, Agostinis P, Apetoh L, Aranda F, Barnaba V, Bloy N, Bracci L, Breckpot K, Brough D, Buqué A, Castro MG, Cirone M, Colombo MI, Cremer I, Demaria S, Dini L, Eliopoulos AG, Faggioni A, Formenti SC, Fučíková J, Gabriele L, Gaipl US, Galon J, Garg A, Ghiringhelli F, Giese NA, Guo ZS, Hemminki A, Herrmann M, Hodge JW, Holdenrieder S, Honeychurch J, Hu HM, Huang X, Illidge TM, Kono K, Korbelik M, Krysko DV, Loi S, Lowenstein PR, Lugli E, Ma Y, Madeo F, Manfredi AA, Martins I, Mavilio D, Menger L, Merendino N, Michaud M, Mignot G, Mossman KL, Multhoff G, Oehler R, Palombo F, Panaretakis T, Pol J, Proietti E, Ricci JE, Riganti C, Rovere-Querini P, Rubartelli A, Sistigu A, Smyth MJ, Sonnemann J, Spisek R, Stagg J, Sukkurwala AQ, Tartour E, Thorburn A, Thorne SH, Vandenabeele P, Velotti F, Workenhe ST, Yang H, Zong WX, Zitvogel L, Kroemer G, Galluzzi L.
PMID: 25941621
Oncoimmunology. 2014 Dec 13;3(9):e955691. doi: 10.4161/21624011.2014.955691. eCollection 2014 Oct.

Apoptotic cells have long been considered as intrinsically tolerogenic or unable to elicit immune responses specific for dead cell-associated antigens. However, multiple stimuli can trigger a functionally peculiar type of apoptotic demise that does not go unnoticed by the...

Cite
Kepp O, Senovilla L, Vitale I, et al. Consensus guidelines for the detection of immunogenic cell death. Oncoimmunology. 2014;3(9):e955691doi: 10.4161/21624011.2014.955691.
Kepp, O., Senovilla, L., Vitale, I., Vacchelli, E., Adjemian, S., Agostinis, P., Apetoh, L., Aranda, F., Barnaba, V., Bloy, N., Bracci, L., Breckpot, K., Brough, D., Buqué, A., Castro, M. G., Cirone, M., Colombo, M. I., Cremer, I., Demaria, S., Dini, L., Eliopoulos, A. G., Faggioni, A., Formenti, S. C., Fučíková, J., Gabriele, L., Gaipl, U. S., Galon, J., Garg, A., Ghiringhelli, F., Giese, N. A., Guo, Z. S., Hemminki, A., Herrmann, M., Hodge, J. W., Holdenrieder, S., Honeychurch, J., Hu, H. M., Huang, X., Illidge, T. M., Kono, K., Korbelik, M., Krysko, D. V., Loi, S., Lowenstein, P. R., Lugli, E., Ma, Y., Madeo, F., Manfredi, A. A., Martins, I., Mavilio, D., Menger, L., Merendino, N., Michaud, M., Mignot, G., Mossman, K. L., Multhoff, G., Oehler, R., Palombo, F., Panaretakis, T., Pol, J., Proietti, E., Ricci, J. E., Riganti, C., Rovere-Querini, P., Rubartelli, A., Sistigu, A., Smyth, M. J., Sonnemann, J., Spisek, R., Stagg, J., Sukkurwala, A. Q., Tartour, E., Thorburn, A., Thorne, S. H., Vandenabeele, P., Velotti, F., Workenhe, S. T., Yang, H., Zong, W. X., Zitvogel, L., Kroemer, G., & Galluzzi, L. (2014). Consensus guidelines for the detection of immunogenic cell death. Oncoimmunology, 3(9), e955691. https://doi.org/10.4161/21624011.2014.955691
Kepp, Oliver, et al. "Consensus guidelines for the detection of immunogenic cell death." Oncoimmunology vol. 3,9 (2014): e955691. doi: https://doi.org/10.4161/21624011.2014.955691
Kepp O, Senovilla L, Vitale I, Vacchelli E, Adjemian S, Agostinis P, Apetoh L, Aranda F, Barnaba V, Bloy N, Bracci L, Breckpot K, Brough D, Buqué A, Castro MG, Cirone M, Colombo MI, Cremer I, Demaria S, Dini L, Eliopoulos AG, Faggioni A, Formenti SC, Fučíková J, Gabriele L, Gaipl US, Galon J, Garg A, Ghiringhelli F, Giese NA, Guo ZS, Hemminki A, Herrmann M, Hodge JW, Holdenrieder S, Honeychurch J, Hu HM, Huang X, Illidge TM, Kono K, Korbelik M, Krysko DV, Loi S, Lowenstein PR, Lugli E, Ma Y, Madeo F, Manfredi AA, Martins I, Mavilio D, Menger L, Merendino N, Michaud M, Mignot G, Mossman KL, Multhoff G, Oehler R, Palombo F, Panaretakis T, Pol J, Proietti E, Ricci JE, Riganti C, Rovere-Querini P, Rubartelli A, Sistigu A, Smyth MJ, Sonnemann J, Spisek R, Stagg J, Sukkurwala AQ, Tartour E, Thorburn A, Thorne SH, Vandenabeele P, Velotti F, Workenhe ST, Yang H, Zong WX, Zitvogel L, Kroemer G, Galluzzi L. Consensus guidelines for the detection of immunogenic cell death. Oncoimmunology. 2014 Dec 13;3(9):e955691. doi: 10.4161/21624011.2014.955691. eCollection 2014 Oct. PMID: 25941621; PMCID: PMC4292729.
Copy Download .nbib Format: NLM
Mechanisms of sterile inflammation.

Frontiers in immunology

Rubartelli A, Lotze MT, Latz E, Manfredi A.
PMID: 24319446
Front Immunol. 2013 Nov 22;4:398. doi: 10.3389/fimmu.2013.00398. eCollection 2013.

No abstract available.

Cite
Rubartelli A, Lotze MT, Latz E, et al. Mechanisms of sterile inflammation. Front Immunol. 2013;4:398doi: 10.3389/fimmu.2013.00398.
Rubartelli, A., Lotze, M. T., Latz, E., & Manfredi, A. (2013). Mechanisms of sterile inflammation. Frontiers in immunology, 4398. https://doi.org/10.3389/fimmu.2013.00398
Rubartelli, Anna, et al. "Mechanisms of sterile inflammation." Frontiers in immunology vol. 4 (2013): 398. doi: https://doi.org/10.3389/fimmu.2013.00398
Rubartelli A, Lotze MT, Latz E, Manfredi A. Mechanisms of sterile inflammation. Front Immunol. 2013 Nov 22;4:398. doi: 10.3389/fimmu.2013.00398. eCollection 2013. PMID: 24319446; PMCID: PMC3837241.
Copy Download .nbib Format: NLM
Restoring microenvironmental redox and pH homeostasis inhibits neoplastic cell growth and migration: therapeutic efficacy of esomeprazole plus sulfasalazine on 3-MCA-induced sarcoma.

Oncotarget

Balza E, Castellani P, Moreno PS, Piccioli P, Medraño-Fernandez I, Semino C, Rubartelli A.
PMID: 28978047
Oncotarget. 2017 Jun 27;8(40):67482-67496. doi: 10.18632/oncotarget.18713. eCollection 2017 Sep 15.

Neoplastic cells live in a stressful context and survive thanks to their ability to overcome stress. Thus, tumor cell responses to stress are potential therapeutic targets. We selected two such responses in melanoma and sarcoma cells: the xc- antioxidant...

Cite
Balza E, Castellani P, Moreno PS, et al. Restoring microenvironmental redox and pH homeostasis inhibits neoplastic cell growth and migration: therapeutic efficacy of esomeprazole plus sulfasalazine on 3-MCA-induced sarcoma. Oncotarget. 2017;8(40):67482-67496doi: 10.18632/oncotarget.18713.
Balza, E., Castellani, P., Moreno, P. S., Piccioli, P., Medraño-Fernandez, I., Semino, C., & Rubartelli, A. (2017). Restoring microenvironmental redox and pH homeostasis inhibits neoplastic cell growth and migration: therapeutic efficacy of esomeprazole plus sulfasalazine on 3-MCA-induced sarcoma. Oncotarget, 8(40), 67482-67496. https://doi.org/10.18632/oncotarget.18713
Balza, Enrica, et al. "Restoring microenvironmental redox and pH homeostasis inhibits neoplastic cell growth and migration: therapeutic efficacy of esomeprazole plus sulfasalazine on 3-MCA-induced sarcoma." Oncotarget vol. 8,40 (2017): 67482-67496. doi: https://doi.org/10.18632/oncotarget.18713
Balza E, Castellani P, Moreno PS, Piccioli P, Medraño-Fernandez I, Semino C, Rubartelli A. Restoring microenvironmental redox and pH homeostasis inhibits neoplastic cell growth and migration: therapeutic efficacy of esomeprazole plus sulfasalazine on 3-MCA-induced sarcoma. Oncotarget. 2017 Jun 27;8(40):67482-67496. doi: 10.18632/oncotarget.18713. eCollection 2017 Sep 15. PMID: 28978047; PMCID: PMC5620187.
Copy Download .nbib Format: NLM
The role of sonoelastography in the differential diagnosis of neck nodules.

Journal of ultrasound

Rubaltelli L, Stramare R, Tregnaghi A, Scagliori E, Cecchelero E, Mannucci M, Gallinaro E, Beltrame V.
PMID: 23396686
J Ultrasound. 2009 Sep;12(3):93-100. doi: 10.1016/j.jus.2009.05.001. Epub 2009 Jun 21.

Sonoelastography is an imaging technique that provides information on tissue elasticity. Its use as a diagnostic procedure is based on the premise that pathological processes like cancer alter the physical characteristics of the involved tissue. Ultrasonographic studies of the...

Cite
Rubaltelli L, Stramare R, Tregnaghi A, et al. The role of sonoelastography in the differential diagnosis of neck nodules. J Ultrasound. 2009;12(3):93-100doi: 10.1016/j.jus.2009.05.001.
Rubaltelli, L., Stramare, R., Tregnaghi, A., Scagliori, E., Cecchelero, E., Mannucci, M., Gallinaro, E., & Beltrame, V. (2009). The role of sonoelastography in the differential diagnosis of neck nodules. Journal of ultrasound, 12(3), 93-100. https://doi.org/10.1016/j.jus.2009.05.001
Rubaltelli, L, et al. "The role of sonoelastography in the differential diagnosis of neck nodules." Journal of ultrasound vol. 12,3 (2009): 93-100. doi: https://doi.org/10.1016/j.jus.2009.05.001
Rubaltelli L, Stramare R, Tregnaghi A, Scagliori E, Cecchelero E, Mannucci M, Gallinaro E, Beltrame V. The role of sonoelastography in the differential diagnosis of neck nodules. J Ultrasound. 2009 Sep;12(3):93-100. doi: 10.1016/j.jus.2009.05.001. Epub 2009 Jun 21. PMID: 23396686; PMCID: PMC3552973.
Copy Download .nbib Format: NLM
Different Members of the IL-1 Family Come Out in Different Ways: DAMPs vs. Cytokines?.

Frontiers in immunology

Carta S, Lavieri R, Rubartelli A.
PMID: 23745123
Front Immunol. 2013 May 24;4:123. doi: 10.3389/fimmu.2013.00123. eCollection 2013.

Intercellular communications control fundamental biological processes required for the survival of multicellular organisms. Secretory proteins are among the most important messengers in this network of information. Proteins destined to the extracellular environment contain a signal sequence with the necessary...

Cite
Carta S, Lavieri R, Rubartelli A. Different Members of the IL-1 Family Come Out in Different Ways: DAMPs vs. Cytokines?. Front Immunol. 2013;4:123doi: 10.3389/fimmu.2013.00123.
Carta, S., Lavieri, R., & Rubartelli, A. (2013). Different Members of the IL-1 Family Come Out in Different Ways: DAMPs vs. Cytokines?. Frontiers in immunology, 4123. https://doi.org/10.3389/fimmu.2013.00123
Carta, Sonia, et al. "Different Members of the IL-1 Family Come Out in Different Ways: DAMPs vs. Cytokines?." Frontiers in immunology vol. 4 (2013): 123. doi: https://doi.org/10.3389/fimmu.2013.00123
Carta S, Lavieri R, Rubartelli A. Different Members of the IL-1 Family Come Out in Different Ways: DAMPs vs. Cytokines?. Front Immunol. 2013 May 24;4:123. doi: 10.3389/fimmu.2013.00123. eCollection 2013. PMID: 23745123; PMCID: PMC3662868.
Copy Download .nbib Format: NLM
Dysregulated IL-1β Secretion in Autoinflammatory Diseases: A Matter of Stress?.

Frontiers in immunology

Carta S, Semino C, Sitia R, Rubartelli A.
PMID: 28421072
Front Immunol. 2017 Apr 04;8:345. doi: 10.3389/fimmu.2017.00345. eCollection 2017.

Infectious and sterile inflammation is induced by activation of innate immune cells. Triggering of toll-like receptors by pathogen-associated molecular pattern or damage-associated molecular pattern (PAMP or DAMP) molecules generates reactive oxygen species that in turn induce production and activation...

Cite
Carta S, Semino C, Sitia R, et al. Dysregulated IL-1β Secretion in Autoinflammatory Diseases: A Matter of Stress?. Front Immunol. 2017;8:345doi: 10.3389/fimmu.2017.00345.
Carta, S., Semino, C., Sitia, R., & Rubartelli, A. (2017). Dysregulated IL-1β Secretion in Autoinflammatory Diseases: A Matter of Stress?. Frontiers in immunology, 8345. https://doi.org/10.3389/fimmu.2017.00345
Carta, Sonia, et al. "Dysregulated IL-1β Secretion in Autoinflammatory Diseases: A Matter of Stress?." Frontiers in immunology vol. 8 (2017): 345. doi: https://doi.org/10.3389/fimmu.2017.00345
Carta S, Semino C, Sitia R, Rubartelli A. Dysregulated IL-1β Secretion in Autoinflammatory Diseases: A Matter of Stress?. Front Immunol. 2017 Apr 04;8:345. doi: 10.3389/fimmu.2017.00345. eCollection 2017. PMID: 28421072; PMCID: PMC5378711.
Copy Download .nbib Format: NLM
Joint analysis of the intention to vaccinate and to use contact tracing app during the COVID-19 pandemic.

Scientific reports

Caserotti M, Girardi P, Tasso A, Rubaltelli E, Lotto L, Gavaruzzi T.
PMID: 35039550
Sci Rep. 2022 Jan 17;12(1):793. doi: 10.1038/s41598-021-04765-9.

Pharmacological and non-pharmacological measures will overlap for a period after the onset of the pandemic, playing a strong role in virus containment. We explored which factors influence the likelihood to adopt two different preventive measures against the COVID-19 pandemic....

Cite
Caserotti M, Girardi P, Tasso A, et al. Joint analysis of the intention to vaccinate and to use contact tracing app during the COVID-19 pandemic. Sci Rep. 2022;12(1):793doi: 10.1038/s41598-021-04765-9.
Caserotti, M., Girardi, P., Tasso, A., Rubaltelli, E., Lotto, L., & Gavaruzzi, T. (2022). Joint analysis of the intention to vaccinate and to use contact tracing app during the COVID-19 pandemic. Scientific reports, 12(1), 793. https://doi.org/10.1038/s41598-021-04765-9
Caserotti, Marta, et al. "Joint analysis of the intention to vaccinate and to use contact tracing app during the COVID-19 pandemic." Scientific reports vol. 12,1 (2022): 793. doi: https://doi.org/10.1038/s41598-021-04765-9
Caserotti M, Girardi P, Tasso A, Rubaltelli E, Lotto L, Gavaruzzi T. Joint analysis of the intention to vaccinate and to use contact tracing app during the COVID-19 pandemic. Sci Rep. 2022 Jan 17;12(1):793. doi: 10.1038/s41598-021-04765-9. PMID: 35039550.
Copy Download .nbib Format: NLM
Left lower limb fasciitis due to sigmoid colonic perforated diverticulitis: a rare case of colocutaneous fistula.

Journal of surgical case reports

Rubartelli A, Cocchi L, Solari N, Cafiero F, Minuto M, Bertoglio S.
PMID: 32904662
J Surg Case Rep. 2020 Aug 31;2020(8):rjaa264. doi: 10.1093/jscr/rjaa264. eCollection 2020 Aug.

Up to 25% of patients with acute diverticulitis develop complicated disease. Colocutaneous fistula with lower limb fasciitis secondary to complicated diverticulitis is a rare event. A 71-year-old woman with Class 3 obesity and Type 2 diabetes was admitted to...

Cite
Rubartelli A, Cocchi L, Solari N, et al. Left lower limb fasciitis due to sigmoid colonic perforated diverticulitis: a rare case of colocutaneous fistula. J Surg Case Rep. 2020;2020(8):rjaa264doi: 10.1093/jscr/rjaa264.
Rubartelli, A., Cocchi, L., Solari, N., Cafiero, F., Minuto, M., & Bertoglio, S. (2020). Left lower limb fasciitis due to sigmoid colonic perforated diverticulitis: a rare case of colocutaneous fistula. Journal of surgical case reports, 2020(8), rjaa264. https://doi.org/10.1093/jscr/rjaa264
Rubartelli, Alice, et al. "Left lower limb fasciitis due to sigmoid colonic perforated diverticulitis: a rare case of colocutaneous fistula." Journal of surgical case reports vol. 2020,8 (2020): rjaa264. doi: https://doi.org/10.1093/jscr/rjaa264
Rubartelli A, Cocchi L, Solari N, Cafiero F, Minuto M, Bertoglio S. Left lower limb fasciitis due to sigmoid colonic perforated diverticulitis: a rare case of colocutaneous fistula. J Surg Case Rep. 2020 Aug 31;2020(8):rjaa264. doi: 10.1093/jscr/rjaa264. eCollection 2020 Aug. PMID: 32904662; PMCID: PMC7458146.
Copy Download .nbib Format: NLM
Therapeutic efficacy of proton transport inhibitors alone or in combination with cisplatin in triple negative and hormone sensitive breast cancer models.

Cancer medicine

Balza E, Carlone S, Carta S, Piccioli P, Cossu V, Marini C, Sambuceti G, Rubartelli A, Castellani P.
PMID: 34796694
Cancer Med. 2022 Jan;11(1):183-193. doi: 10.1002/cam4.4371. Epub 2021 Nov 18.

Triple negative breast cancers (TNBCs) are very aggressive and have a poor prognosis due to lack of efficacious therapies. The only effective treatment is chemotherapy that however is frequently hindered by the occurrence of drug resistance. We approached this...

Cite
Balza E, Carlone S, Carta S, et al. Therapeutic efficacy of proton transport inhibitors alone or in combination with cisplatin in triple negative and hormone sensitive breast cancer models. Cancer Med. 2021;11(1):183-193doi: 10.1002/cam4.4371.
Balza, E., Carlone, S., Carta, S., Piccioli, P., Cossu, V., Marini, C., Sambuceti, G., Rubartelli, A., & Castellani, P. (2022). Therapeutic efficacy of proton transport inhibitors alone or in combination with cisplatin in triple negative and hormone sensitive breast cancer models. Cancer medicine, 11(1), 183-193. https://doi.org/10.1002/cam4.4371
Balza, Enrica, et al. "Therapeutic efficacy of proton transport inhibitors alone or in combination with cisplatin in triple negative and hormone sensitive breast cancer models." Cancer medicine vol. 11,1 (2022): 183-193. doi: https://doi.org/10.1002/cam4.4371
Balza E, Carlone S, Carta S, Piccioli P, Cossu V, Marini C, Sambuceti G, Rubartelli A, Castellani P. Therapeutic efficacy of proton transport inhibitors alone or in combination with cisplatin in triple negative and hormone sensitive breast cancer models. Cancer Med. 2022 Jan;11(1):183-193. doi: 10.1002/cam4.4371. Epub 2021 Nov 18. PMID: 34796694; PMCID: PMC8704177.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 24 entries